Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Hyperlipidemia”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Not applicableStudy completedNCT00536965
What this trial is testing

Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets

Who this might be right for
HyperlipidemiasAtherosclerosisCoronary Heart Disease+3 more
AstraZeneca 951
Testing effectiveness (Phase 2)Ended earlyNCT00437892
What this trial is testing

Statins to Reduce D-dimer Levels in Patients With Venous Thrombosis

Who this might be right for
Venous ThromboembolismHypercholesterolemia
Università degli Studi dell'Insubria 10
Not applicableStudy completedNCT00536796
What this trial is testing

Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets

Who this might be right for
HyperlipidemiasAtherosclerosisCoronary Heart Disease+3 more
AstraZeneca 1,096
Not applicableStudy completedNCT00660764
What this trial is testing

Assessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observational Study (HEROS)

Who this might be right for
HypercholesterolemiaCoronary Heart DiseasePeripheral Vascular Disease+2 more
AstraZeneca
Post-approval studies (Phase 4)Study completedNCT00833976
What this trial is testing

Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia

Who this might be right for
High TriglyceridesHypercholesterolemiaSchizophrenia+2 more
Massachusetts General Hospital 65
Not applicableStudy completedNCT04920825
What this trial is testing

Sacha Inchi Oil Supplementation in 3Hs

Who this might be right for
Endocrine and Metabolic Secondary Hypertension
Universiti Sains Malaysia 54
Not applicableEnded earlyNCT05834673
What this trial is testing

VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN)

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)Coronary Heart Disease (CHD)Cerebrovascular Disease+1 more
Monash University 6
Early research (Phase 1)UnknownNCT00291824
What this trial is testing

Cardiovascular Lifestyle Study: Effects and Expense of a Cardiovascular Risk Reduction Clinic in Primary Care

Who this might be right for
HypertensionHyperlipidemiaHyperglycemia+2 more
Caroline Medical Group 670
Not applicableStudy completedNCT02215408
What this trial is testing

MEDication Focused Outpatient Care for Underutilization of Secondary Prevention

Who this might be right for
DiabetesHyperlipidemiaHypertension+1 more
Korey Kennelty 402
Not applicableNot Yet RecruitingNCT07273513
What this trial is testing

"Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Revascularization Patients

Who this might be right for
HypertensionDiabete MellitusHyperlipidemia+2 more
China National Center for Cardiovascular Diseases 951
Not applicableStudy completedNCT00236210
What this trial is testing

Controlled Trial of a Novel Community-based Primary and Secondary Cardiovascular Prevention Program

Who this might be right for
Vascular DiseaseDiabetesHypertension+2 more
Group Health Centre 422
Post-approval studies (Phase 4)Active Not RecruitingNCT06249165
What this trial is testing

VictORION-INCLUSION: Evaluating Inclisiran for Cholesterol Managment in Heart Disease

Who this might be right for
Atherosclerotic Cardiovascular Disease
Duke University 130
Not applicableUnknownNCT03065543
What this trial is testing

Hyperlipidemia Therapy TERCET Zabrze Registry

Who this might be right for
HyperlipidemiasSecondary Prevention
Silesian Centre for Heart Diseases 25,000
Testing effectiveness (Phase 2)Ended earlyNCT00004466
What this trial is testing

Pilot Study of Atorvastatin in Children With Chronic Hyperlipidemia Secondary to Nephrotic Syndrome

Who this might be right for
Nephrotic SyndromeHyperlipidemia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 5
Not applicableStudy completedNCT02251834
What this trial is testing

Hispanic Secondary Stroke Prevention Initiative

Who this might be right for
Stroke
University of Miami 200
Not applicableStudy completedNCT00347217
What this trial is testing

Observational to Investigate the Efficacy of CRESTOR 5mg in Reaching LDL-C Target Goals in Patients Who Are at High Risk for a Cardiovascular Event

Who this might be right for
Hypercholesteremia
AstraZeneca 3,840
Not applicableNot Yet RecruitingNCT07382414
What this trial is testing

Electronic Letters to Improve Patient Activation in IHD: The NUDGE-IHD Trial

Who this might be right for
Coronary Artery DiseaseHypercholesterolemiaLipoprotein(a)+1 more
Tor Biering-Sørensen 100,000
Post-approval studies (Phase 4)Study completedNCT01409434
What this trial is testing

Long Term Antihypertensive Exposure and Adverse Metabolic Effects: PEAR Follow-Up Study

Who this might be right for
Drug Induced HyperglycemiaSecondary Hyperlipidemia
University of Florida 44
Not applicableLooking for participantsNCT06615609
What this trial is testing

"Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Coronary Artery Bypass Graft Patients or Post Percutaneous Coronary Intervention Patients

Who this might be right for
Post Coronary Artery Bypass GraftingHypertensionDiabetes Mellitus+2 more
China National Center for Cardiovascular Diseases 536
Not applicableStudy completedNCT05974345
What this trial is testing

In Silico Study Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Patients With Established Cardiovascular Disease

Who this might be right for
Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals 204,691
Load More Results